-+ 0.00%
-+ 0.00%
-+ 0.00%

NKGen Biotech Korea Corrects Order Backlog Table in Third-Quarter Report

PUBT·11/13/2026 03:26:28
Listen to the news
NKGen Biotech Korea Corrects Order Backlog Table in Third-Quarter Report
  • NKGen Biotech Korea corrected order-backlog entries in its third-quarter 2026 report on November 13, citing typographical errors.
  • The corrected table lists outstanding orders of KRW 971.9 billion for the December 19, 2016, NK Vue contract.
  • Two other corrected entries show backlogs of KRW 380.21 million and KRW 3.67 billion.
  • Total outstanding orders remained unchanged at KRW 1.51 trillion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NKGen Biotech Korea Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000344), on November 13, 2026, and is solely responsible for the information contained therein.